- Home
- PLX vs PIM Comparison
PLX vs PIM Comparison
Compare PLX & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLX | PIM |
|---|---|---|
| Founded | 1993 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 153.2M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | PIM |
|---|---|---|
| Price | $2.67 | $3.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 757.1K | 40.4K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | 0.05 |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.69 | $63.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.53 | $3.07 |
| 52 Week High | $3.19 | $3.50 |
Technical Indicators
Market Signals| Indicator | PLX | PIM |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 48.30 |
| Support Level | $2.59 | $3.14 |
| Resistance Level | $2.71 | $3.23 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 87.78 | 37.60 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.